This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2000;283:1413.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Optimal management of people living with HIV infection is a moving target, thanks to an expanding repertoire of antiretroviral drugs. Now, an updated version of the Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, by the Panel on Clinical Practices for the Treatment of HIV Infection (a joint effort of the Department of Health and Human Services and the Henry J. Kaiser Family Foundation) is available to help clinicians sort out these options.

The latest version includes recommendations for the use of recently developed resistance tests, which help determine if a patient is infected with an HIV strain that is resistant to one or more antiretroviral drugs. Such tests can help guide rational selection of a new drug regimen. Other features include a new section on the goals of therapy (such as restoring or preserving immunologic function) and strategies for achieving these . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?